Unum Therapeutics Inc (UMRX)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-01-15 | 2025-01-14 | PP Planned purchase |
Chief Commercial Officer Officer |
43,750
+2085.3%
7.60USD 332,413 |
43,750 +2085.3% | 7.60 | USD 332,413 | |
| 2023-06-13 | 2023-06-09 | B Purchase |
Fairmount Funds Management LLC Large shareholder |
800,000
+32.4%
12.00USD 9,600,000 |
800,000 +32.4% | 12.00 | USD 9,600,000 | |
| 2022-06-21 | 2022-06-16 | B Purchase |
Fairmount Funds Management LLC Large shareholder |
1,200,000
+94.3%
8.25USD 9,900,000 |
1,200,000 +94.3% | 8.25 | USD 9,900,000 | |
| 2021-04-28 | 2021-04-26 | S Sale |
Chief Financial Officer Officer |
17,813
-82.3%
8.86USD 157,823 |
17,813 -82.3% | 8.86 | USD 157,823 | |
| 2020-08-18 | 2020-08-18 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
101,000
+2.4%
2.62USD 264,620 |
101,000 +2.4% | 2.62 | USD 264,620 | |
| 2020-08-18 | 2020-08-17 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
250,000
+6.2%
2.57USD 642,500 |
250,000 +6.2% | 2.57 | USD 642,500 | |
| 2020-08-18 | 2020-08-14 | B Purchase |
Venrock Healthcare Capital Partners III, L.P. Large shareholder |
100,000
+2.6%
2.30USD 230,000 |
100,000 +2.6% | 2.30 | USD 230,000 | |
| 2020-10-08 | 2020-05-12 | S Sale | Large shareholder |
98,200
-3.1%
0.46USD 45,545 |
98,200 -3.1% | 0.46 | USD 45,545 | |
| 2020-10-08 | 2020-05-11 | S Sale | Large shareholder |
77,719
-2.4%
0.45USD 35,160 |
77,719 -2.4% | 0.45 | USD 35,160 | |
| 2020-10-08 | 2020-05-11 | S Sale | Large shareholder |
22,281
-0.7%
0.46USD 10,336 |
22,281 -0.7% | 0.46 | USD 10,336 | |
| 2020-10-08 | 2020-05-08 | S Sale | Large shareholder |
100,000
-2.9%
0.46USD 46,390 |
100,000 -2.9% | 0.46 | USD 46,390 | |
| 2020-10-08 | 2020-05-07 | S Sale | Large shareholder |
100,000
-2.9%
0.41USD 41,430 |
100,000 -2.9% | 0.41 | USD 41,430 | |
| 2020-10-08 | 2020-05-06 | S Sale | Large shareholder |
1,800
-0.1%
0.40USD 722 |
1,800 -0.1% | 0.40 | USD 722 | |
| 2020-10-08 | 2020-05-05 | S Sale | Large shareholder |
135,484
-3.7%
0.40USD 54,437 |
135,484 -3.7% | 0.40 | USD 54,437 | |
| 2020-10-08 | 2020-05-04 | S Sale | Large shareholder |
4,795
-0.1%
0.40USD 1,921 |
4,795 -0.1% | 0.40 | USD 1,921 | |
| 2020-10-08 | 2020-05-01 | S Sale | Large shareholder |
800
-0.0%
0.41USD 328 |
800 -0.0% | 0.41 | USD 328 | |
| 2020-10-08 | 2020-04-30 | S Sale | Large shareholder |
75,994
-2.0%
0.40USD 30,557 |
75,994 -2.0% | 0.40 | USD 30,557 | |
| 2020-10-08 | 2020-04-29 | S Sale | Large shareholder |
382,927
-9.4%
0.41USD 155,507 |
382,927 -9.4% | 0.41 | USD 155,507 | |
| 2020-10-08 | 2020-04-28 | S Sale | Large shareholder |
15,048
-0.4%
0.41USD 6,168 |
15,048 -0.4% | 0.41 | USD 6,168 | |
| 2020-10-08 | 2020-04-27 | S Sale | Large shareholder |
242,579
-5.6%
0.40USD 97,808 |
242,579 -5.6% | 0.40 | USD 97,808 | |
| 2020-10-08 | 2020-04-20 | S Sale | Large shareholder |
12,606
-0.3%
0.40USD 5,050 |
12,606 -0.3% | 0.40 | USD 5,050 | |
| 2020-10-08 | 2020-04-17 | S Sale | Large shareholder |
65,540
-1.5%
0.39USD 25,574 |
65,540 -1.5% | 0.39 | USD 25,574 | |
| 2020-10-08 | 2020-04-16 | S Sale | Large shareholder |
600
-0.0%
0.38USD 230 |
600 -0.0% | 0.38 | USD 230 | |
| 2020-10-08 | 2020-04-15 | S Sale | Large shareholder |
82,782
-1.8%
0.38USD 31,797 |
82,782 -1.8% | 0.38 | USD 31,797 | |
| 2020-10-08 | 2020-04-14 | S Sale | Large shareholder |
44,006
-1.0%
0.40USD 17,602 |
44,006 -1.0% | 0.40 | USD 17,602 | |
| 2020-10-08 | 2020-04-14 | S Sale | Large shareholder |
54,967
-1.2%
0.40USD 22,119 |
54,967 -1.2% | 0.40 | USD 22,119 | |
| 2020-10-08 | 2020-04-09 | S Sale | Large shareholder |
420,292
-8.3%
0.33USD 138,150 |
420,292 -8.3% | 0.33 | USD 138,150 | |
| 2020-10-08 | 2020-04-08 | S Sale | Large shareholder |
100
-0.0%
0.35USD 35 |
100 -0.0% | 0.35 | USD 35 | |
| 2020-10-08 | 2020-04-07 | S Sale | Large shareholder |
11,400
-0.2%
0.35USD 3,990 |
11,400 -0.2% | 0.35 | USD 3,990 | |
| 2020-10-08 | 2020-04-06 | S Sale | Large shareholder |
50,080
-1.0%
0.35USD 17,528 |
50,080 -1.0% | 0.35 | USD 17,528 | |
| 2019-03-26 | 2019-03-25 | PS Planned sale |
Chief Scientific Officer |
11,485
-100.0%
4.12USD 47,334 |
11,485 -100.0% | 4.12 | USD 47,334 | |
| 2019-02-26 | 2019-02-25 | PS Planned sale |
Chief Scientific Officer Officer |
11,485
-100.0%
4.25USD 48,853 |
11,485 -100.0% | 4.25 | USD 48,853 | |
| 2018-12-28 | 2018-12-26 | PS Planned sale |
Ettenberg Seth Chief Scientific Officer Officer |
11,485
-100.0%
4.05USD 46,487 |
11,485 -100.0% | 4.05 | USD 46,487 | |
| 2018-11-26 | 2018-11-26 | PS Planned sale |
Ettenberg Seth Chief Scientific Officer Officer |
11,485
-100.0%
7.00USD 80,444 |
11,485 -100.0% | 7.00 | USD 80,444 | |
| 2018-10-29 | 2018-10-25 | PS Planned sale |
Ettenberg Seth Chief Scientific Officer Officer |
11,485
-100.0%
8.46USD 97,201 |
11,485 -100.0% | 8.46 | USD 97,201 | |
| 2018-09-26 | 2018-09-25 | PS Planned sale |
Ettenberg Seth Chief Scientific Officer Officer |
11,485
-100.0%
12.47USD 143,181 |
11,485 -100.0% | 12.47 | USD 143,181 | |
| 2018-04-05 | 2018-04-03 | B Purchase |
FMR LLC See Remark 1 |
94,052
+26.3%
12.00USD 1,128,624 |
94,052 +26.3% | 12.00 | USD 1,128,624 | |
| 2018-04-03 | 2018-04-03 | B Purchase |
Booth Bruce Non-Executive Director |
94,052
+2.9%
12.00USD 1,128,624 |
94,052 +2.9% | 12.00 | USD 1,128,624 | |
| 2018-04-03 | 2018-04-03 | B Purchase |
Atlas Venture Fund IX, L.P. Large shareholder |
94,052
+2.9%
12.00USD 1,128,624 |
94,052 +2.9% | 12.00 | USD 1,128,624 | |
| 2018-04-03 | 2018-04-03 | B Purchase |
Ratcliffe Liam Non-Executive Director |
275,000
+44.2%
12.00USD 3,300,000 |
275,000 +44.2% | 12.00 | USD 3,300,000 | |
| 2018-04-03 | 2018-04-03 | B Purchase |
Ratcliffe Liam Non-Executive Director |
275,000
+44.2%
12.00USD 3,300,000 |
275,000 +44.2% | 12.00 | USD 3,300,000 |